To be or not to be?

July 27, 2015 | Human Longevity launched in March of last year, the latest of J. Craig Venter’s genomics startups, headquartered in San Diego. The vision was grand: sequence 100,000 human genomes a year and "change the way medicine is practiced by helping to shift to a more preventive, genomic-based medicine model,” Venter said at the company’s launch. “Our goal is not necessarily lengthening life, but extending a healthier, high performing and more productive life span."

Now in my third year of elder care, two relatives in poor health living beyond 90, I question how the sandwich generation will experience a healthier, high performing and more productive life span when most of our energy is directed outward.

See more at: BioIT World.com